PCI Pharma Services is acquiring an entire equity stake in Ajinomoto Althea Inc. (Althea), a U.S.-based sterile fill-finish ...

PCI Pharma Services ("PCI") – a leading global contract development and manufacturing organization (CDMO) focused on ...

The startup, Veraxa, has $253 million in cash and is raising a crossover funding round to support a pipeline of T cell ...

Lotte Biologics Co., the biotech arm of Lotte Group, said Thursday it has signed a deal with an Asia-based biotech company ...

Acquisition creates a world-class large-scale manufacturing hub in San Diego region with state-of-the-art aseptic facilities ...

The drugs still need to prove their effectiveness in human trials, but they might be ready for wide use before a vaccine. Israel has also developed its own antibody compound, joining countries ...

Antibody-drug conjugates combined with immunotherapy have redefined the standard of care for advanced bladder cancer, ...

In the first phase 3 trial to show the superiority of a TROP2-targeted antibody-drug conjugate and an immunotherapy agent in first-line triple-negative breast cancer (TNBC), Gilead Sciences ...

No writing assistance was utilized in the production of this manuscript. Several antibody–drug conjugates (ADCs), using different combinations of antibody, cytotoxic agents and linkers ...